Does the upstaging of breast cancer based on grade and hormone receptor status in AJCC 8 change your treatment recommendations?  

Is it still acceptable to deliver hypofractionation for what was previously a Stage I TN breast cancer, now Stage IIIA? Should RNI be considered? Or even concurrent chemotherapy?



Answer from: Radiation Oncologist at Academic Institution